Related Experiment Video
Updated: Jun 16, 2026

A Proximal Culture Method to Study Paracrine Signaling Between Cells
Published on: August 28, 2018
Ovarian cancer creates a suppressive microenvironment to escape immune elimination
Refika Yigit1, Leon F A G Massuger, Carl G Figdor
1Department of Obstetrics and Gynecology (791), Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands. R.Yigit@obgyn.umcn.nl
Background:
Considering the high mortality rate of ovarian cancer due to the absence of curative treatment in advanced stage or at recurrence, new therapeutic strategies are urgently needed. Immunotherapy is one of these strategies that yielded promising results in fundamental and animal research in the past years. However, implementation in clinical practice remains poor. The aim of this review is to gain insight into the mechanisms of interaction between ovarian cancer and the immune system in order to develop better immunotherapeutic strategies.
Methods:
We searched the published literature for studies focusing on interactions between ovarian cancer and the immune system, with emphasis on outcome data in order to create a knowledge base that is well grounded in clinical reality.
Results:
The immunological response against cancer is a critical balance between immune-activating and immune-suppressing mechanisms. Besides the immune-activating tumor infiltrating lymphocytes (TILs), immune-suppressive regulatory T-cells (Tregs), tolerance-inducing plasmacytoid dendritic cells (pDCs), B7-H4+ macrophages, immune-suppressive cytokines such as IL10 and TGF-beta are also found in the tumor environment. Myeloid-derived suppressive cells (MDSCs) are recently found to have a significant role in immune suppression in ovarian cancer in murine studies. Furthermore, vascular endothelial growth factor (VEGF) is also known to have an immune-suppressing role besides its angiogenic role. All those concerted mechanisms result in the creation of an environment where the cancer is invincible and can grow unhampered.
Conclusion:
Further knowledge of the mechanisms involved is needed to develop better strategies and improve the clinical applicability of immunotherapy. Effective immunotherapy must combine immune-activating strategies with elimination of immune-suppressing mechanisms. We believe that tilting the balance from an immune-suppressive to an immune-active environment may have an enormous impact on the disease.
Insights
New ovarian cancer immunotherapies are needed due to high mortality. Understanding the immune system
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Ovarian cancer has a high mortality rate with limited curative options for advanced or recurrent disease.
- Immunotherapy shows promise in preclinical research but faces challenges in clinical application.
- Developing novel therapeutic strategies is crucial for improving patient outcomes.
Purpose of the Study:
- To review the complex interactions between ovarian cancer and the immune system.
- To identify key mechanisms driving immune evasion in ovarian cancer.
- To inform the development of more effective immunotherapeutic strategies.
Main Methods:
- Literature search focused on ovarian cancer-immune system interactions.
- Emphasis on studies with clinical outcome data.
- Synthesis of findings to create a clinically relevant knowledge base.
Main Results:
- Ovarian cancer involves a balance of immune-activating (e.g., tumor-infiltrating lymphocytes) and immune-suppressing factors.
- Key suppressors include regulatory T-cells, plasmacytoid dendritic cells, B7-H4+ macrophages, IL10, TGF-beta, myeloid-derived suppressive cells, and VEGF.
- These factors create an immunosuppressive tumor microenvironment, hindering anti-cancer immunity.
Conclusions:
- Deeper understanding of ovarian cancer's immune microenvironment is essential for advancing immunotherapy.
- Effective immunotherapy requires combining immune activation with suppression of immune-inhibitory mechanisms.
- Shifting the tumor microenvironment from suppressive to active holds significant therapeutic potential.
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Tumor Immunotherapy
Oogenesis
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

